Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
Cellebrite Di Ltd (NASDAQ: CLBTW) delivers critical Digital Intelligence solutions for modern investigative challenges. This news hub provides stakeholders with essential updates about the company’s technological advancements, regulatory compliance, and market positioning.
Access consolidated information on product launches, partnership announcements, and financial disclosures relevant to CLBTW’s role in digital forensics and corporate investigations. Our curated collection serves investors and professionals needing to monitor developments in SaaS-based investigative tools, eDiscovery innovations, and cybersecurity capabilities.
Key updates include earnings reports, leadership changes, and technology patents across Cellebrite’s Case-to-Closure platform. All content undergoes strict verification to ensure accuracy and relevance for decision-makers in both public sector and corporate environments.
Bookmark this page for streamlined access to CLBTW’s latest developments in legally compliant data analysis solutions. Regularly updated to reflect the company’s progress in addressing evolving digital security demands.
Cellebrite (Nasdaq: CLBT), a leader in Digital Investigative solutions, has patented its Remote Mobile Collection technology. This innovation, available in Cellebrite's SaaS platforms Endpoint Mobile Now and Endpoint Inspector, enables corporate investigators to perform immediate, targeted remote data collection from mobile devices.
Key benefits include:
- Time and cost savings for businesses
- Faster device access and analysis
- Convenience for device owners, who can retain their devices during collection
- Ability to collect data from multiple devices simultaneously
- Improved data accessibility with results available within hours
According to Cellebrite's 2024 Industry Trends Survey, 83% of respondents rely on multiple tools for data collection. This patented technology aims to streamline this process, particularly in today's hybrid work environment.
Cellebrite DI (Nasdaq: CLBT) has announced the results of its completed redemption of all outstanding warrants. Key points include:
- 99.4% of outstanding Public Warrants were exercised, with 4,645 exercised for cash and 19,878,580 exercised cashlessly.
- 116,224 unexercised Public Warrants were redeemed for $11,622.40.
- All 9,666,667 Private Placement Warrants were exercised cashlessly.
- Public Warrants have stopped trading on Nasdaq and been delisted.
- The redemption does not affect the trading of Cellebrite's Ordinary Shares (CLBT).
Cellebrite (Nasdaq: CLBT) has announced the availability of Pathfinder in the Cloud with Amazon Web Services (AWS), enhancing its investigative analytics solution for law enforcement agencies. This cloud-based offering allows customers to access Pathfinder through Amazon's secure Virtual Private Cloud (VPC), providing flexible deployment options and scalable resources.
Key features of Pathfinder include AI-driven data analysis, slang identification, explicit image categorization, Optical Character Recognition (OCR), and Automated Translation Services. The cloud deployment eliminates the need for physical servers and secure rooms, offering cost-effective scaling, rapid resource commissioning, and high availability.
This update aims to accelerate digital evidence analysis, reduce investigation time, and improve case resolution efficiency for law enforcement agencies of all sizes.
Cellebrite DI (Nasdaq: CLBT) has announced the 'Redemption Fair Market Value' for its previously announced warrant redemption. The company will redeem all outstanding warrants at $0.10 per warrant on September 16, 2024. Warrant holders can exercise their warrants for cash at $11.50 per Ordinary Share or on a 'cashless basis' before the redemption date. Based on the Redemption Fair Market Value of $16.72, holders exercising warrants on a cashless basis will receive 0.342 Ordinary Shares per Warrant.
The company has obtained a ruling from Israeli Tax Authorities exempting certain qualified holders from potential tax withholding upon share issuance. Unexercised warrants after the redemption date will be void. The last trading day for Public Warrants on Nasdaq will be September 13, 2024.
Cellebrite (NASDAQ: CLBT) announced its second-quarter 2024 financial results with revenue of $95.7 million, marking a 25% year-over-year increase due to a 27% growth in subscription revenue. The company reported an Annual Recurring Revenue (ARR) of $345.9 million, up 26% YoY, and an adjusted EBITDA of $21.6 million with a 22.6% margin.
GAAP net loss was $23.8 million, while non-GAAP net income was $22.9 million. The company also raised its 2024 outlook for revenue and adjusted EBITDA, forecasting full-year revenue between $390 million and $398 million and adjusted EBITDA between $90 million and $95 million.
Cellebrite expanded its operations by forming Cellebrite Federal Solutions and acquiring Cyber Technology Services, Inc. Additionally, it partnered with Relativity to enhance mobile device collection and processing solutions. The company also announced the redemption of 30 million outstanding warrants and the issuance of 5 million Price Adjustment Shares.
Cellebrite DI (Nasdaq: CLBT) has announced the redemption of all outstanding warrants to purchase ordinary shares at $0.10 per warrant, effective September 16, 2024. This includes public and private placement warrants. Warrantholders can choose to exercise their warrants for cash at $11.50 per share or surrender them on a 'cashless basis' before the redemption date. The company has obtained a ruling from Israeli Tax Authorities exempting certain qualified holders from potential tax withholding upon share issuance. Unexercised warrants after the redemption date will be void. The last trading day for public warrants on Nasdaq is expected to be September 13, 2024.
Cellebrite (NASDAQ: CLBT), a leader in digital investigative solutions, has appointed Troy K. Richardson to its Board of Directors. Richardson, a tech veteran with over 30 years of experience, brings significant operational and sales expertise from leading technology companies. He currently serves on the Unisys Board and previously held senior roles at PTC, DXC, Oracle, SAP, HP, Novell, and IBM. With Richardson's addition, Cellebrite's board now consists of 10 directors.
Thomas Hogan, Executive Chairman, expressed enthusiasm about Richardson's appointment, highlighting his deep knowledge of the software industry and broad leadership experience. Richardson stated his excitement to join Cellebrite, praising the company's leadership position in digital investigation and intelligence gathering, as well as its culture of innovation and social responsibility.
Cellebrite (NASDAQ: CLBT), a global leader in Digital Investigative solutions, has appointed Sigalit Shavit as its first-ever Chief Information Officer (CIO), effective August 1, 2024. With over 30 years of experience, Shavit joins Cellebrite's Leadership Team, reporting directly to CEO Yossi Carmil. Her role will be important in scaling the company's innovation and customer support capabilities.
Shavit's appointment comes at a time when Cellebrite's technical innovation is vital in combating sophisticated criminals and managing growing digital evidence. She will focus on supporting business needs, addressing cyber threats, leveraging AI, and accelerating innovation. Recognized as one of the Top 25 Women Leaders in Cybersecurity, Shavit brings valuable experience from her previous roles at FedEx Express, ECI Telecom, CyberArk, and KTrust.
Cellebrite (NASDAQ: CLBT) has launched Cellebrite Federal Solutions to enhance its strategic relationship with the U.S. federal government. This move includes the acquisition of Cyber Technology Services, Inc. (CyTech), expanding Cellebrite's capabilities in cybersecurity and digital forensics. The new unit, led by Erik Sachwitz, aims to address the evolving needs of U.S. federal customers and unlock more opportunities.
Key highlights:
- Acquisition of CyTech to broaden Cellebrite's expertise
- Establishment of a dedicated unit for federal sector
- Appointment of four renowned independent directors
- Focus on AI-driven Case-to-Closure platform
- U.S. federal customers generated 19% of Cellebrite's annual recurring revenue in the public sector in 2023, up 21% from the previous year
Cellebrite (NASDAQ: CLBT), a leader in Digital Investigative solutions, will report its Q2 2024 financial results on August 15, 2024, before market open. A live conference call and webcast will follow at 8:30 a.m. ET to review the results and discuss the company's outlook for 2024. Investors can access the call via a designated call-in number or through a live webcast. Historical financial data and supplemental information will be available on Cellebrite's investor relations website. A replay and transcript of the call will also be accessible later.
FAQ
What is the current stock price of Cellebrite Di (CLBTW)?
